International Biotechnology (LON:IBT – Get Free Report) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 705.43 and traded as high as GBX 953.98. International Biotechnology shares last traded at GBX 932, with a volume of 110,828 shares traded.
International Biotechnology Price Performance
The firm has a 50-day moving average of GBX 839 and a 200-day moving average of GBX 705.43. The stock has a market cap of £300.97 million, a PE ratio of 19.23 and a beta of 0.21.
International Biotechnology (LON:IBT – Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported GBX (11.42) EPS for the quarter. International Biotechnology had a return on equity of 13.67% and a net margin of 90.66%. Equities analysts forecast that International Biotechnology will post 0.9435943 EPS for the current fiscal year.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Further Reading
- Five stocks we like better than International Biotechnology
- How to Effectively Use the MarketBeat Ratings Screener
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- Insider Buying Explained: What Investors Need to Know
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
